Femoral Vein Central Venous Catheter Market Size, Trends, Share, Growth, and Opportunity Forecast, 2024 - 2031 Global Industry Analysis By Product Type (Single Lumen, Double Lumen, Triple Lumen, and Others), By Material Type (Silicone, and Polyurethane), By Application (Hemodialysis, Emergency Care, Oncology, Surgical Procedures, and Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Dialysis Centers) and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

The Global Femoral Vein Central Venous Catheter Market was valued at USD 392.1 Million in 2023 and is anticipated to reach a value of USD 622.6 Million by 2031 expanding at a CAGR of 6.0% between 2024 and 2031.       

Femoral vein central venous catheters (CVCs) are advanced medical devices, which are thin, long, flexible tubes inserted into the femoral vein, typically designed for medications, nutritional support, and providing fluids or blood for emergency or long-term treatment. These tubes are also used to draw blood and body fluids from vein. Depending on the product type, the market is classified into single lumen, double lumen, triple lumen, and others. In short, femoral vein central venous catheters are essential tools in various healthcare settings, particularly in emergency and critical care settings. They provide efficient way to deliver fluids, medications, and nutrition directly into the bloodstream. The market is influenced by factors such as surge in geriatric population, growing prevalence of chronic diseases, focus on minimally invasive procedures, and increasing healthcare expenditure. The femoral vein central venous catheters are extensively used in hospitals, clinics, ambulatory surgical centers, and dialysis centers areas.

To learn more about this report, request a free sample copy

Femoral Vein Central Venous Catheter Market Major Driving Forces

Surge in Geriatric Population: The increasing geriatric population is the significant driver of femoral vein central venous catheters market. The rising geriatric population leading to an increased incidence of health issues such as cardiovascular diseases, urological disorders, and other diseases drives the demand for femoral vein central venous catheters.

Growing Prevalence of Chronic Diseases: The increasing number of chronic diseases such as cardiovascular diseases, kidney failure, and cancer necessitate the use of central venous catheters for treatments. Rising prevalence of chronic diseases fuels the demand for femoral vein central venous catheters.

Focus on Minimally Invasive Procedures: The growing preference for minimally invasive procedures is boosting demand for femoral vein central venous catheters. Femoral vein central venous catheters play a crucial role in performing various surgeries and medical procedures.

Increasing Healthcare Expenditure: The rising healthcare expenditure across the globe, coupled with improved access to healthcare services are driving the growth of the femoral vein central venous catheters market. Increased healthcare spending enables better diagnosis, treatment, and management of rare genetic disorders.  

Femoral Vein Central Venous Catheter Market Key Opportunities

Technological Advancements: The growing emphasis on developing technologically advanced solutions provides opportunity for market growth. The growing focus on development of smart catheters with the integration of sensors and smart technology to enable real-time monitoring and early detection of diseases, can further boost market growth.

Expansion in Emerging Markets: Expansion into emerging economies, characterized by improvement of healthcare infrastructure, and increasing healthcare expenditure creates an opportunity for femoral vein central venous catheters market growth.  Market major players can expand their global reach in emerging regions by offering innovative and cost-effective products.

Telemedicine and Remote Monitoring: The rising demand for remote patient monitoring and telemedicine offers lucrative opportunities for femoral vein central venous catheters market growth. The integration of telemedicine with central venous catheter enable remote monitoring and consultation, improving patient outcomes, and reducing the need for frequent hospital visits.

Femoral Vein Central Venous Catheter Market Key Trends

·         Rising demand for minimally invasive procedures leading to development of advanced catheters such as femoral vein central venous catheters

·         The increasing use of central venous catheters with antimicrobial and antithrombogenic coatings to reduce the risk of infections and thrombosis

·         Rising prevalence of chronic diseases requiring long-term venous access, driving the demand for femoral vein central venous catheters

·         An increase in patients with cancer, cardiovascular diseases, and chronic illness drives demand for femoral vein central venous catheters for various treatments

·         Increasing focus on the integration of sensors with robotics and artificial intelligence to enhance catheter performance and diagnostic capabilities

·         The growing trend towards home healthcare for long-term treatments drives demand for femoral vein central venous catheters

·         Market players are developing sensor-based smart catheters tailored for specific requirements, which offer specialized features and functionalities

Region-wise Market Insights

North America accounted for the largest market share at 36.6% in 2023 whereas, Asia Pacific is expected to register the fastest growth, expanding at a CAGR of 6.6% between 2024 and 2031.

To learn more about this report, request a free sample copy

In North America, the demand is driven by advanced healthcare infrastructure, High healthcare expenditure, and adoption of advanced medical technologies. In addition, the presence of strong patient base with cardiovascular diseases, aging population, increasing demand for intensive care, and presence of major global players are other factors drives regional market growth.   In Europe, the market growth is driven by growing aging population, high incidence of infectious diseases, advancements in healthcare technology and growing focus on patient safety. In Asia-Pacific, the market is characterized by rapidly expanding healthcare infrastructure, rapid economic development, shift towards advanced medical devices, and large patient population which has created an increasing demand for femoral vein central venous catheters. The Middle East and Africa has been witnessing a growing demand for femoral vein central venous catheters due to increasing investments in healthcare, and growing prevalence of chronic diseases whereas, in South America, the market is influenced by economic factors, with increasing healthcare expenditure, and improving healthcare infrastructure.

Market Competition Landscape

The global femoral vein central venous catheter market is characterized by intense competition with several key players striving to strengthen their position in market. Major players in the market are heavily investing in research and development to provide innovative and reliable solutions. These companies are focused on product development, research and development investments, and strategic partnerships with other organizations to meet the changing needs of healthcare professionals and improve patient care. Key players in the femoral vein central venous catheter market engage in strategies aimed at gaining a competitive edge. These strategies include product innovation, design differentiation, and the incorporation of sustainable and eco-friendly materials to meet evolving consumer preferences. Established brands leverage their reputation for quality and reliability to maintain market share, while newer entrants focus on disruptive innovations and unique selling propositions.

Key players in the global femoral vein central venous catheter market implement various organic and inorganic strategies to strengthen and improve their market positioning. Prominent players in the market include:

·         Teleflex Medical Pvt. Ltd.

·         Edwards Lifesciences Corporation

·         B. Braun SE

·         BD

·         Abbott Laboratories

·         Smiths Medical, Inc.

·         Baihe Medical

·         Diziwings Technologies Pvt. Ltd.

·         Lepu Medical Technology(Beijing)Co.,Ltd.

·         SCW Medicath Ltd

·         Cook Medical

·         Medtronic plc

·         Boston Scientific Corporation

·         AngioDynamics, Inc.